Floatz logo

Therapeutic Asset Ratings

440 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Everolimus
Ovarian Cancer
Gynaecologisch Oncologisch Centrum ZuidP2/3B (58)
Cediranib
Ovarian Cancer
Yonsei UniversityP3B (57)
Talzenna
Ovarian Cancer
Alexander B Olawaiye, MDP3B (57)
FULVESTRANT
Ovarian Cancer
Terremoto Biosciences Inc.P2B (57)
Tranexamic Acid
Ovarian Cancer
Sheikh Zayed Medical CollegeP4B (56)
Benadryl
Ovarian Cancer
Merck Sharp & Dohme LLCP3B (56)
Sodium Thiosulfate
Ovarian Cancer
National Cancer Center, KoreaP3B (56)
Cetuximab
Ovarian Cancer
Fate TherapeuticsP2B (56)
Eribulin
Ovarian Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP2B (56)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Ovarian Cancer
M.D. Anderson Cancer CenterP2B (56)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Ovarian Cancer
Yonsei UniversityP2B (56)
Palbociclib
Ovarian Cancer
Bristol-Myers SquibbP2B (56)
PREDNISONE TABLETS
Ovarian Cancer
AstraZenecaP2B (56)
TRASTUZUMAB
Ovarian Cancer
Fate TherapeuticsP2B (56)
Adebrelimab
Ovarian Cancer
Obstetrics & Gynecology Hospital of Fudan UniversityP2/3B (56)
Dostarlimab
Ovarian Cancer
AGO Research GmbHP3CCC (55)
Arimidex
Ovarian Cancer
OHSU Knight Cancer InstituteP2CCC (55)
Enzalutamide
Ovarian Cancer
Nuvation Bio Inc.P2CCC (55)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Ovarian Cancer
Regeneron PharmaceuticalsP2CCC (55)
Ipilimumab
Ovarian Cancer
Regeneron PharmaceuticalsP2CCC (55)
com701
Ovarian Cancer
Compugen LtdP1/2CCC (55)
PROPOFOL
Ovarian Cancer
Kaohsiung Medical University Chung-Ho Memorial HospitalP4CCC (54)
Sevoflurane
Ovarian Cancer
Kaohsiung Medical University Chung-Ho Memorial HospitalP4CCC (54)
Alpelisib
Ovarian Cancer
OHSU Knight Cancer InstituteP3CCC (54)
Benmelstobart
Ovarian Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (54)
Showing 51 to 75 of 440 assets
PreviousPage 3 of 18Next